Smallpox is a highly contagious human disease caused by the variola virus. Although the disease was eliminated in 1979 due to its highly contagious nature and historical pathogenicity, with a mortality rate of up to 30%, this virus is an important candidate for biological weapons. Currently, vaccines are the critical measures to prevent this virus infection and spread. In this study, we designed a peptide vaccine using immunoinformatics tools, which have the potential to activate human immunity against variola virus infection efficiently. The design of peptides derives from vaccine-candidate proteins showing protective potential in vaccinia WR strains. Potential non-toxic and nonallergenic T-cell and B-cell binding and cytokine-inducing epitopes were then screened through a priority prediction using special linkers to connect B-cell epitopes and T-cell epitopes, and an appropriate adjuvant was added to the vaccine construction to enhance the immunogenicity of the peptide vaccine. The 3D structure display, docking, and free energy calculation analysis indicate that the binding affinity between the vaccine peptide and Toll-like receptor 3 is high, and the vaccine receptor complex is highly stable. Notably, the vaccine we designed is obtained from the protective protein of the vaccinia and combined with preventive measures to avoid side effects. This vaccine is highly likely to produce an effective and safe immune response against the variola virus infection in the body. IMPORTANCE: In this work, we designed a vaccine with a cluster of multiple T-cell/B-cell epitopes, which should be effective in inducing systematic immune responses against variola virus infection. Besides, this work also provides a reference in vaccine design for preventing monkeypox virus infection, which is currently prevalent.
Background: Bluetongue virus (BTV), an emerging insect vector mediated pathogen affecting both wild ruminants and livestock, has a genome consisting of 10 linear double-stranded RNA genome segments. BTV has a severe economic impact on agriculture in many parts of the world. Current reverse genetics (RG) strategy to rescue BTV mainly rely on in vitro synthesis of RNA transcripts from cloned complimentary DNA (cDNA) corresponding to viral genome segments with the aid of helper plasmids. RNA synthesis is a laborious job which is further complicated with a need for expensive reagents and a meticulous operational procedure. Additionally, the target genes must be cloned into a specific vector to prepare templates for RNA transcription. Result: In this study, we have developed a PCR based BTV RG system with easy two-step transfection. Viable viruses were recovered following a first transfection with the seven helper plasmids and a second transfection with the 10 PCR products on the BSR cells. Further, recovered viruses were characterized with indirect immunofluorescence assays (IFA) and gene sequencing. And the proliferation properties of these viruses were also compared with wild type BTV. Interestingly, we have identified that viruses containing the segment 2 of the genome from reassortant BTV, grew slightly slower than the others. Conclusion: In this study, a convenient PCR based RG platform for BTV is established, and this strategy could be an effective alternative to the original available BTV rescue methods. Furthermore, this RG strategy is likely applicable for other Orbiviruses.
8 April 2024 in Applied Microbiology and Biotechnology
For the development of a competitive ELISA (cELISA) to detect serum antibodies against the Mycoplasma mycoides subsp. Mycoides (Mmm) (strain PG1), the causative agent of contagious bovine pleuropneumonia (CBPP), all the proteins of this pathogen were analyzed. Then, a specific extracellular region of a transmembrane protein with the potential for diagnosis was identified. After that, a monoclonal antibody (Mab) named 3A8 was obtained using this extracellular region as an immunogen. Finally, a cELISA was established with the extracellular domain of this transmembrane protein as the coating antigen, Mab 3A8 as the competitive antibody, and HRP-labeled goat anti-mouse IgG as the enzyme-labeled antibody. This established method was used to detect the antibody dynamic regularity of goats which are artificially immunized Mmm and was also compared with a commercial ELISA kit. Further, the sera of 1011 different cattle from border provinces of China were monitored using a candidate Mab 3A8 cELISA. The detection results of known background sera used in this study indicate that a candidate diagnostic marker was successfully identified by analyzing all the coding proteins of Mmm in this research, and the cELISA established based on the Mab 3A8 against this protein can detect CBPP-positive serum with specificity and has no cross-reaction with other related epidemic disease-positive sera. In addition, we tested the sera collected from the border areas of China using the established ELISA, and no positive sample was detected. The research protocol of the CBPP cELISA established in this study is different from the traditional method, which can greatly reduce the investment of manpower and capital and save development time. We believe that this study’s protocol could serve as a reference for the development of detection methods for mycoplasma and other complex pathogens. Key points: • A Mmm-specific diagnostic marker was obtained based on protein characteristics. • A cELISA was established for CBPP serum antibody detection. • The serological investigation was conducted for CBPP in the border areas of China.
Mycoplasma bovis is a highly infectious pathogenic microorganism that causes various clinical signs in cattle, including pneumonia, arthritis, and mastitis, often resulting in significant economic losses. The adhesion of M. bovis to host cells is a pivotal step in the infection process, which is a complex process involving multiple pathogenic and host proteins. Molecules involved in M. bovis adhesion and colonization are widely recognized as important virulence factors and often implicated in the infection and pathogenesis. In this study, the Mbov_0510 gene of M. bovis was cloned, and the protein encoded by this gene was expressed and purified. The rabbit polyclonal antibody against this protein was also produced. This protein was shown to be a surface protein and to react with the M. bovis -positive serum. The ability of this protein to adhere to host cells was verified using embryonic bovine lung (EBL) and Madin-Darby bovine kidney (MDBK) cells. Furthermore, the adhesion function of this protein was found to be achieved through interaction with heparin on the host cell surface, and the key region of the protein involved in heparin binding was identified. The conservation of the protein encoded by the Mbov_0510 gene was also analyzed. The results of this study suggest that the protein encoded by the Mbov_0510 gene is a heparin-binding surface membrane protein of M. bovis associated with infection. IMPORTANCE: Mycoplasmas lack a cell wall, and the membrane proteins interacting with host cells play essential roles in their infection and proliferation processes. In this study, we identified a membrane protein encoded by Mycoplasma bovis that interacts with heparin on the surface of host cells. Heparin is widely distributed in various cells and tissues of the host and serves as a receptor for the infection and invasion of many pathogenic microorganisms. The ability of M. bovis to invade multiple tissues may be related to its heparin-binding capacity. The heparin-binding protein identified in this study is valuable for further research on the infection and invasion mechanisms of M. bovis .
Mycoplasma bovis , a minimal bacterium but a notorious cattle pathogen, leads to serious economic losses. This pathogen binding to host cells is emerging as a complex process involving a broad range of surface-exposed structures. For mycoplasma, adhering to host tissue is the first and crucial step of infection. It is well known that the molecules contributing to microbial cytoadhesion are important virulence factors. Here, we cloned, expressed, and purified the recombinant protein, which is encoded by MBOVJF4278_00820 , and induced polyclonal antibodies for it in mice. The cytoadhesive properties of this surface-exposed protein were demonstrated on embryonic bovine lung (EBL) and Madin-Darby bovine kidney (MDBK) cells. Furthermore, heparin as the binding target was confirmed, and the characteristics of the interaction between this protein and heparin have also been analyzed. Our data indicate that the surface-associated MBOVJF4278_00820 -encoded protein is a novel adhesion-related factor of Mycoplasma bovis . IMPORTANCE: Adhesins are crucial in facilitating Mycoplasma bovis infection. In this study, we identified a specific Mycoplasma bovis adhesin that interacts with heparin on the surface of host cells. Given that heparin is ubiquitously distributed across a wide range of tissue cells, the identification of the heparin-binding adhesin is significant for elucidating how Mycoplasma bovis targets diverse host cells and triggers a spectrum of clinical manifestations.